Notable Labs Gross Margin 2013-2024 | NTBLQ

Current and historical gross margin for Notable Labs (NTBLQ) over the last 10 years. The current gross profit margin for Notable Labs as of June 30, 2024 is %.
Notable Labs Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-12-31 $-0.00B $-0.00B 100.00%
2022-09-30 $0.00B 0 nan%
2022-06-30 $0.00B 0 nan%
2022-03-31 $0.00B 0 nan%
2021-12-31 $0.00B 0 nan%
2021-09-30 $0.00B 0 nan%
2021-06-30 $0.00B 0 nan%
2021-03-31 $0.00B 0 nan%
2020-12-31 $0.00B 0 nan%
2020-09-30 $0.00B 0 nan%
2020-06-30 $0.00B 0 nan%
2020-03-31 $0.00B 0 nan%
2019-12-31 $0.00B 0 nan%
2019-09-30 $0.00B 0 nan%
2019-06-30 $0.00B 0 nan%
2019-03-31 $0.00B 0 nan%
2018-12-31 $0.00B 0 nan%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00